Cross-reactivity between tumor MHC class I–restricted antigens and an enterococcal bacteriophage
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Phages and cancer immunity Gut bacteria are involved in the education of T cell immune responses, and the intestinal ecosystem influences anticancer immunity. Fluckiger et al. report microbial antigens that might cross-react with antigens associated with tumor cells. They found that a type of intestinal bacteria called enterococci harbor a bacteriophage that modulates immune responses. In mouse models, administration of enterococci containing the bacteriophage boosted T cell responses after treatment with chemotherapy or programmed cell death protein 1 (PD-1) blockade. In humans, the presence of the bacteriophage was associated with improved survival after PD-1 immunotherapy. A fraction of human T cells specific for naturally processed melanoma epitopes appeared to be able to recognize microbial peptides. This “molecular mimicry” may represent cross-reactivity between tumors and microbial antigens. Science , this issue p. 936
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Indeed, bacteriophages as therapeutic strategies could modulate the gut microbiota, immunity, and TME [70, 164–166].”
From Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies (2022) · doi:10.1186/s13045-022-01273-9 · cites this paper as [70]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“an E. hirae strain carrying a prophage from the Siphoviridae family translocates to mLNs and the spleen”
From Impact of the ONCOBIOME network in cancer microbiome research (2025) · cites this paper as [55]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“boosts the T cell-dependent efficacy of cyclophosphamide or PD-1 blockade”
From Impact of the ONCOBIOME network in cancer microbiome research (2025) · cites this paper as [55]
The cited source says what the claim attributes to it.
In the citing paper
“molecular mimicry between microbial and tumor-associated antigens, resulting in cross-reactive T cell responses 55”
From Impact of the ONCOBIOME network in cancer microbiome research (2025) · cites this paper as [55]
The cited source says what the claim attributes to it.
In the citing paper
“Moreover, the gut microbiome’s vast antigen reservoir may facilitate cross-reactivity between bacterial and tumor antigens, thereby enhancing antitumor immune responses (Fluckiger et al., 2020; Naghavian et al., 2023).”
From Microbiota-centered interventions to boost immune checkpoint blockade therapies (2025) · cites this paper as Fluckiger et al., 2020
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trimmomatic: a flexible trimmer for Illumina sequence data
Bolger, A. M., Lohse, M., & Usadel, B. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu170 · Cited by 65,548
SPAdes: A New Genome Assembly Algorithm and Its Applications to Single-Cell Sequencing
Bankevich, A., Nurk, S., Antipov, D., Gurevich, A. A., Dvorkin, M., Kulikov, A. S., Lesin, V. M., Nikolenko, S. I., Pham, S., Prjibelski, A. D., et al. (2012) · Journal of Computational Biology · doi:10.1089/cmb.2012.0021 · Cited by 25,987
Prokka: rapid prokaryotic genome annotation
Seemann, T. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu153 · Cited by 18,818
Guindon, S., Dufayard, J.-F., Lefort, V., Anisimova, M., Hordijk, W., & Gascuel, O. (2010) · Systematic Biology · doi:10.1093/sysbio/syq010 · Cited by 18,376
Genome engineering using the CRISPR-Cas9 system
Ran, F. A., Hsu, P. D., Wright, J., Agarwala, V., Scott, D. A., & Zhang, F. (2013) · Nature Protocols · doi:10.1038/nprot.2013.143 · Cited by 11,133
Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche
Sato, T., Vries, R. G., Snippert, H. J., van de Wetering, M., Barker, N., Stange, D. E., van Es, J. H., Abo, A., Kujala, P., Peters, P. J., et al. (2009) · Nature · doi:10.1038/nature07935 · Cited by 7,204
OrthoMCL: Identification of Ortholog Groups for Eukaryotic Genomes
Li, L., Stoeckert, C. J., & Roos, D. S. (2003) · Genome Research · doi:10.1101/gr.1224503 · Cited by 5,707
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Routy, B., Le Chatelier, E., Derosa, L., Duong, C. P. M., Alou, M. T., Daillère, R., Fluckiger, A., Messaoudene, M., Rauber, C., Roberti, M. P., et al. (2018) · Science · doi:10.1126/science.aan3706 · Cited by 5,671
Self-citationAnticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
Vétizou, M., Pitt, J. M., Daillère, R., Lepage, P., Waldschmitt, N., Flament, C., Rusakiewicz, S., Routy, B., Roberti, M. P., Duong, C. P. M., et al. (2015) · Science · doi:10.1126/science.aad1329 · Cited by 3,488
Self-citationImmune checkpoint targeting in cancer therapy: toward combination strategies with curative potential
Sharma, P., & Allison, J. P. (2015) · Cell · doi:10.1016/j.cell.2015.03.030 · Cited by 2,345
Cited by
Items 201–300 of 402
Liu, G., Huang, W., Chen, L., Tayier, N., You, L., Hamza, M., Tian, X., Wang, H., Nie, G., Zhu, M., et al. (2023) · Nano Today · doi:10.1016/j.nantod.2023.101993 · Cited by 17
Factors Influencing Microbiota in Modulating Vaccine Immune Response: A Long Way to Go
Ponziani, F. R., Coppola, G., Rio, P., Caldarelli, M., Borriello, R., Gambassi, G., Gasbarrini, A., & Cianci, R. (2023) · Vaccines · doi:10.3390/vaccines11101609 · Cited by 19
Advancements in understanding tumor‑resident bacteria and their application in cancer therapy
Luo, Y., Huang, X., Wang, R., Lin, Y., Sun, J., Li, K., Wang, D. Y., Yan, Y., & Qiao, Y. (2025) · Military Medical Research · doi:10.1186/s40779-025-00623-1 · Cited by 31
Extracellular vesicle-based liquid biopsies in cancer: Future biomarkers for oral cancer
Minami, S., Chikazu, D., Ochiya, T., & Yoshioka, Y. (2023) · Translational Oncology · doi:10.1016/j.tranon.2023.101786 · Cited by 17
Promising and Minimally Invasive Biomarkers: Targeting Melanoma
Spiliopoulou, P., Lopes, C. D. H., & Spreafico, A. (2023) · Cells · doi:10.3390/cells13010019 · Cited by 16
Tumor-targeting bacteria as immune stimulants – the future of cancer immunotherapy?
Mowday, A. M., van de Laak, J., Fu, Z., Henare, K. L., Dubois, L. J., Lambin, P., Theys, J., & Patterson, A. V. (2024) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2024.2311653 · Cited by 19
Wheeler, R., & Boneca, I. G. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2395099 · Cited by 18
Self-citationDóra, D., Kiraly, P., Somodi, C., Ligeti, B., Dulka, E., Gálffy, G., & Lohinai, Z. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05835-y · Cited by 18
Potential Effects of Regulating Intestinal Flora on Immunotherapy for Liver Cancer
Yan, X.-D., Bai, L., Qi, P., Lv, J., Song, X., & Zhang, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411387 · Cited by 16
Gao, H., Wang, Y., Zhao, Y., Jiao, X., Guo, Z., Zheng, L., Li, Y., Su, Y., Wang, Z., Bai, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-66733-5 · Cited by 16
Integrating functional metagenomics to decipher microbiome–immune interactions
Sardar, P., Almeida, A., & Pedicord, V. A. (2024) · Immunology and Cell Biology · doi:10.1111/imcb.12798 · Cited by 16
Zhou, Z., Lv, Y., Zuo, A., Zhu, X., Xu, Y., Zuo, L., Xu, H., Liu, S., Zhang, Y., Weng, S., et al. (2025) · hLife · doi:10.1016/j.hlife.2025.05.008 · Cited by 16
Gut microbiota as a regulator of vaccine efficacy: implications for personalized vaccination
Lu, Q., Feng, Y., Wang, H., Zhu, K., Teng, L., Yue, M., & Li, Y. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2563709 · Cited by 17
Influence of Caudovirales Phages on Humoral Immunity in Mice
Владимирович, Ч. А., Kozlova, Y., Константинович, Б. И., Morozova, V. V., Kravchuk, B. I., Ushakova, T. A., Bardasheva, A. V., Zelentsova, E. A., Allaf, L. A., Tikunov, A. Y., et al. (2021) · Viruses · doi:10.3390/v13071241 · Cited by 16
Solving the puzzle of what makes immunotherapies work
Ma, X., & Chan, T. A.-T. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.06.011 · Cited by 15
Intestinal microbiota: A bridge between intermittent fasting and tumors
Liu, J., Shao, N., Qiu, H., Zhao, J., Chen, C., Wan, J., He, Z., Zhao, X., & Xu, L. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115484 · Cited by 17
Shinkawa, T., Tokita, S., Nakatsugawa, M., Kikuchi, Y., Kanaseki, T., & Torigoe, T. (2021) · OncoImmunology · doi:10.1080/2162402x.2020.1870062 · Cited by 17
The Microbiome in Advanced Melanoma: Where Are We Now?
Fortman, D. D., Hurd, D. E., & Davar, D. (2023) · Current Oncology Reports · doi:10.1007/s11912-023-01431-3 · Cited by 14
Microbial influence on triggering and treatment of host cancer: An intestinal barrier perspective
Zhang, H., Wu, J., Li, N., Wu, R., & Chen, W. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188989 · Cited by 15
Ghazi, B., Harmak, Z., Rghioui, M., Kone, A.-S., Ghanmi, A. E., & Badou, A. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1423232 · Cited by 15
Reens, A. L., Cabral, D. J., Liang, X., Norton, J. E., Therien, A. G., Hazuda, D. J., & Swaminathan, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.643255 · Cited by 16
Research Progress of Biomarkers for Immune Checkpoint Inhibitors on Digestive System Cancers
Wang, J., Ma, X., Ma, Z., Ma, Y., Wang, J., & Cao, B. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.810539 · Cited by 15
Oh, J. H., & Rehermann, B. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2100426 · Cited by 13
Microbiome modulation of antigen presentation in tolerance and inflammation
He, Y., Mohapatra, G., Asokan, S., Nobs, S. P., & Elinav, E. (2024) · Current Opinion in Immunology · doi:10.1016/j.coi.2024.102471 · Cited by 13
Wang, R., Li, W., Cao, H., & Zhang, L. (2025) · Biology · doi:10.3390/biology14030243 · Cited by 17
Gong, X., Shen, L., Xie, J., Liu, D., Xie, Y., & Liu, D. (2023) · Helicobacter · doi:10.1111/hel.13011 · Cited by 13
Li, W., Chen, Q., Fan, J., Han, Z., Song, W., Zeng, X., & Zhang, X. (2024) · Advanced Materials · doi:10.1002/adma.202402532 · Cited by 18
The role of microbiota in tumorigenesis, progression and treatment of bladder cancer
Peng, Z., Zhuang, J., & Shen, B. (2023) · Microbiome Research Reports · doi:10.20517/mrr.2023.47 · Cited by 15
Zhang, L. L., Wu, Z., Li, J. Y., Li, H., Liu, Z. M., Wang, J., & Tan, B. (2024) · animal · doi:10.1016/j.animal.2024.101220 · Cited by 12
Yin, Q., Ni, J., & Ying, J. (2024) · Immunity Inflammation and Disease · doi:10.1002/iid3.1263 · Cited by 13
Phylogeny and disease associations of a widespread and ancient intestinal bacteriophage lineage
de Jonge, P. A., van den Born, B. H., Zwinderman, A. H., Nieuwdorp, M., Dutilh, B. E., & Herrema, H. (2024) · Nature Communications · doi:10.1038/s41467-024-50777-0 · Cited by 14
Microbial metabolites for cancer immunotherapy: Current evidence and future directions
Wang, X., Liang, J.-J., Duan, X., & Chen, G. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.10.005 · Cited by 12
Tao, H., Mao, K., Zhang, Z., Wei, W., Huang, X., Chen, Y., Mei, S., & Tian, X. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.108020 · Cited by 13
The emerging role of the gut microbiome in cancer cell plasticity and therapeutic resistance
Mondal, P., & Meeran, S. M. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10138-7 · Cited by 12
From mucosal infection to successful cancer immunotherapy
Goubet, A.-G., Rouanne, M., Derosa, L., Kroemer, G., & Zitvogel, L. (2023) · Nature Reviews Urology · doi:10.1038/s41585-023-00784-5 · Cited by 11
Self-citationYang, H., Chen, J., Li, J., Zhang, Z., Zhao, K., Yin, X., Wang, Z., Zhu, G., Yan, X., Jiang, Z., et al. (2024) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2024.10.014 · Cited by 14
Modulation of oral vaccine efficacy by the gut microbiota
Hou, Y., Li, J., & Wu, Y. (2025) · npj Vaccines · doi:10.1038/s41541-025-01240-8 · Cited by 12
Principles and Terminology for Host–Microbiome–Drug Interactions
Heirali, A., Moossavi, S., Arrieta, M., & Coburn, B. A. (2023) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofad195 · Cited by 13
Weber, D., Meedt, E., Poeck, H., Orberg, E. T., Hiergeist, A., Gessner, A., & Holler, E. (2024) · Visceral Medicine · doi:10.1159/000538303 · Cited by 14
Sha, J., Chen, K.-C., Liu, Z.-B., Li, W., Lu, Y.-S., Liu, S., Ma, J.-K., Qu, D., & Sun, Y. (2024) · European Journal of Nutrition · doi:10.1007/s00394-024-03378-y · Cited by 12
Impact of the microbiome on tumor immunity
McCoy, K. D., & Mager, L. F. (2021) · Current Opinion in Immunology · doi:10.1016/j.coi.2021.01.002 · Cited by 11
Microbial molecules, metabolites, and malignancy
Thomas, R. M. (2025) · Neoplasia · doi:10.1016/j.neo.2025.101128 · Cited by 11
Friends close, enemies closer: the complex role of the microbiome in antitumor immunity
Patra, D., Dev, G., Hand, T. W., & Overacre-Delgoffe, A. E. (2025) · Current Opinion in Immunology · doi:10.1016/j.coi.2025.102537 · Cited by 11
Molecular mimicry as a driver of T cell-mediated tumour immunity
Rossjohn, J., Nezi, L., Walz, J. S., Tagliamonte, M., & Buonaguro, L. (2025) · Trends in Immunology · doi:10.1016/j.it.2025.07.012 · Cited by 11
Purcell, M., Ackland, J., Staples, K. J., Freeman, A. T., & Wilkinson, T. M. A. (2025) · European Respiratory Review · doi:10.1183/16000617.0284-2024 · Cited by 12
Douadi, C., Lamy-Besnier, Q., Theodorou, I., Schiettekatte, O., Sbardella, Y., Brot, L., Costantini, P. E., Saporetti, R., Danielli, A., Calvaresi, M., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116726 · Cited by 11
Altamirano, F. L. G., Subedi, D., Beiers, M., Bucher, M. J., Dahlman, S., Patel, D. M., Parker, M., Korneev, D., Robinson, M. J., Pragastis, K., et al. (2026) · Nature Medicine · doi:10.1038/s41591-026-04301-0 · Cited by 11
Crosstalk between gut microbiota and cancer chemotherapy: current status and trends
Yang, S., Hao, S., Ye, H., & Zhang, X. (2024) · Discover Oncology · doi:10.1007/s12672-024-01704-8 · Cited by 11
Nudel, R., Allesøe, R. L., Thompson, W. K., Werge, T. M., Rasmussen, S., & Benros, M. E. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02888-1 · Cited by 10
Gut reactions: harnessing microbial metabolism to fuel next-generation cancer immunotherapy
Almonte, A. A., & Zitvogel, L. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2025-011540 · Cited by 9
Self-citationMicrobiome dysbiosis and chemotherapy resistance in acute myeloid leukemia (AML)
Tian, M., Samarkhazan, H. S., Alemohammad, S. S., Fakhraei, M., Tavakoli, F., Shams, A., & Zeynalabadi, A. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00891-8 · Cited by 11
Khalil, M., & Tsao, M. (2025) · Cancers · doi:10.3390/cancers17132199 · Cited by 9
Wong, M., Barbulescu, P., Coburn, B. A., & Reguera-Nuñez, E. (2021) · Microbes and Infection · doi:10.1016/j.micinf.2021.104804 · Cited by 9
The impact of antigenic molecular mimicry on anti-cancer T-cell immune response
Tagliamonte, M., & Buonaguro, L. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1009247 · Cited by 9
Mining the Gut Microbiota for Microbial-Based Therapeutic Strategies in Cancer Immunotherapy
Li, B., Gong, T., Hao, Y., Zhou, X., & Cheng, L. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.721249 · Cited by 9
Interaction of microbiota, mucosal malignancies, and immunotherapy—Mechanistic insights
Mager, L. F., Krause, T., & McCoy, K. D. (2024) · Mucosal Immunology · doi:10.1016/j.mucimm.2024.03.007 · Cited by 8
The gut microbiome in lung cancer: from pathogenesis to precision therapy
Shi, M. K., Wang, L., Hu, W., & Liang, Z. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1606684 · Cited by 8
Toward a consensus on the tumor microbiota: Evidence, standards, and interpretation
Duan, T., Rosenbaum, A., Chandra, V., Tiraboschi, L., Rescigno, M., McAllister, F. M., Straussman, R., & Meisel, M. (2026) · Cancer Cell · doi:10.1016/j.ccell.2026.02.011 · Cited by 8
Diet–microbiome synergy underlies obesity-associated immunotherapy efficacy
Desharnais, L., Swaby, A. M., Messaoudene, M., Doré, S., Yu, M. W., Fiset, B., Breton, V., Ponce, M., Hu, Y., Wilson, L., et al. (2026) · Nature · doi:10.1038/s41586-026-10750-x · Cited by 9
Self-citationMicrobiota-associated mechanisms in colorectal cancer
González, A., Fullaondo, A., & Odriozola, A. (2024) · Advances in genetics · doi:10.1016/bs.adgen.2024.05.002 · Cited by 8
Liu, S., Pan, Y., Zheng, C., Zheng, Q., Du, Y., Zheng, Y., Tang, H., Liu, X., Mou, J., Zeng, X. Y., et al. (2025) · mBio · doi:10.1128/mbio.03873-24 · Cited by 8
Qi, Z., Zhao, J., Li, Y., Zhang, B., Hu, S., Chen, Y., Ma, J., Shu, Y., Wang, Y., & Cheng, P. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.982180 · Cited by 10
The Value of Microbes in Cancer Neoantigen Immunotherapy
Tian, J., & Ma, J. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15082138 · Cited by 8
Hazra, R., Chattopadhyay, S., Mallick, A., Gayen, S., & Roy, S. (2024) · Medical Oncology · doi:10.1007/s12032-024-02416-3 · Cited by 8
Talpin, A., Maia, A. R. R., Carpier, J.-M., Kulakowski, G., Aubergeon, L., Kervevan, J., Gaal, C., Strozzi, F., Billerey, C., Amable, L., et al. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-010192 · Cited by 9
Self-citationLeveraging intratumoral probiotics for pancreatic cancer immunotherapy via xenophagy
Li, B., Liu, G., Zhu, Y., Chen, L., Zhang, N., Zhu, X., Sun, Y., Liu, X., Liu, W., Ma, Y., et al. (2026) · Cell Host & Microbe · doi:10.1016/j.chom.2026.02.010 · Cited by 7
Microbiome‐driven anticancer therapy: A step forward from natural products
Guan, Y., Wu, D., Wang, H., & Liu, N. (2024) · mLife · doi:10.1002/mlf2.12118 · Cited by 7
Harnessing microbial antigens as cancer antigens: a promising avenue for cancer immunotherapy
Zhang, T., Zhang, X., Chen, J., Zhang, X., & Zhang, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1411490 · Cited by 10
Microbiota mechanisms in cancer progression and therapy
Zhang, X., Fam, K. T., Dai, T., & Hang, H. C. (2025) · Cell chemical biology · doi:10.1016/j.chembiol.2025.04.005 · Cited by 9
The intestinal virome: lessons from animal models
Chaffringeon, L., Lamy-Besnier, Q., Debarbieux, L., & Sordi, L. D. (2021) · Current Opinion in Virology · doi:10.1016/j.coviro.2021.09.016 · Cited by 9
Self-citationThe Urogenital System’s Role in Diseases: A Synopsis
Zerdan, M. B., Moukarzel, R., Naji, N. S., Bilen, Y., & Nagarajan, A. (2022) · Cancers · doi:10.3390/cancers14143328 · Cited by 8
Hilakivi-Clarke, L. A., Verma, V., McDermott, M., Koak, P., & Andrade, F. D. O. (2022) · Frontiers in Microbiomes · doi:10.3389/frmbi.2022.1049688 · Cited by 7
Immune characteristics associated with lymph node metastasis in early-stage NSCLC
Zhang, Z., Li, L., Gao, Y., Xiao, X., Ji, L., Zhou, Z., Jiang, J., Liu, S., An, J., Deng, P., et al. (2023) · Cellular Oncology · doi:10.1007/s13402-023-00873-y · Cited by 8
Delivery Mode Impacts Gut Bacteriophage Colonization During Infancy
Subramanian, P., Romero-Soto, H. N., Stern, D., Maxwell, G. L., Levy, S., & Hourigan, S. K. (2025) · Gut Microbes Reports · doi:10.1080/29933935.2025.2464631 · Cited by 8
Effect of Holder pasteurization and UV-C irradiation on bacteriophage titres in human milk
Stinson, L. F., Geddes, D. T., & Furfaro, L. L. (2023) · FEMS Microbiology Letters · doi:10.1093/femsle/fnad057 · Cited by 7
Wen, W., Su, R., Liu, Y., Feng, Z., Li, Y., Li, J., Huang, Z., Zhang, F., Gao, S., Ma, Y., et al. (2026) · Cell Host & Microbe · doi:10.1016/j.chom.2026.01.016 · Cited by 6
Chen, Q., Feng, X., Wang, J., Zhu, H., Bo, Z., Wang, B., & Zhao, Z. (2026) · European Journal of Cancer · doi:10.1016/j.ejca.2026.116581 · Cited by 7
Qian, L.-M., Wang, S., Zhou, W., Qin, Z., Wang, Y., Zhao, Q., & Xu, R. (2025) · Briefings in Bioinformatics · doi:10.1093/bib/bbaf208 · Cited by 6
Leveraging gut microbiota for enhanced immune checkpoint blockade in solid tumor therapy
Hu, J., Feng, T., Zhang, L., Zhou, Q., & Zhu, L. (2025) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003687 · Cited by 8
Microbiome unlocks cancer immunotherapeutic potential: State of the art and future
Luo, H.-Y., Cao, L., Zhou, K., Xiao, Y., Li, Z., Liu, B., & Bu, L. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.08.001 · Cited by 6
Chakrawarti, A., Cromarty, R. T., Basting, C. M., Anderson, J., Schroeder, T. A., Escandón-Vargas, K., Shields‐Cutler, R. R., Langat, R., Swanson, E., Soon‐Shiong, P., et al. (2026) · Clinical Infectious Diseases · doi:10.1093/cid/ciag369 · Cited by 6
Pragmatic Expectancy on Microbiota and Non-Small Cell Lung Cancer: A Narrative Review
Stella, G. M., Scialò, F., Bortolotto, C., Agustoni, F., Sanci, V., Saddi, J., Casali, L., Corsico, A. G., & Bianco, A. (2022) · Cancers · doi:10.3390/cancers14133131 · Cited by 7
Guo, Z., Lei, Y., & Wang, Q. (2024) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2024.12692 · Cited by 7
Cui, J., Liu, W.-H., Zang, Y.-X., Zhang, C., Zou, L., Sun, H., Pan‐Hammarström, Q., & Ren, H. (2022) · Virus Research · doi:10.1016/j.virusres.2022.198913 · Cited by 6
The Regulation of Nucleic Acid Vaccine Responses by the Microbiome
Johnson, A. M. F., Hager, K., Alameh, M., Van, P., Potchen, N. B., Mayer-Blackwell, K., Fiore-Gartland, A. J., Minot, S. S., Lin, P. J. C., Tam, Y. K., et al. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2300196 · Cited by 6
Mechanisms of Anti-PD Therapy Resistance in Digestive System Neoplasms
Wu, Y., Jiang, X., Yu, Z., Xing, Z., Ma, Y., & Qing, H. (2024) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/0115748928269276231120103256 · Cited by 6
Silva, C. A. C., Almonte, A. A., & Zitvogel, L. (2025) · Biomolecules · doi:10.3390/biom15040504 · Cited by 6
Self-citationKarthikeyan, E., & Srinivasan, S. (2025) · Biomedical Materials & Devices · doi:10.1007/s44174-025-00320-6 · Cited by 9
Xu, W., Hao, X., Tang, Y., Peng, Y., Liu, X., Zhou, M., Han, R., Wu, J., & 向大雄 (2025) · Advanced Functional Materials · doi:10.1002/adfm.202422196 · Cited by 5
Szállási, Z., Prósz, A. G., Sztupinszki, Z. M., & Moldvay, J. (2024) · OncoImmunology · doi:10.1080/2162402x.2024.2324493 · Cited by 5
Self-citationMicrobiome-modulated immunotherapy in oncology: Current applications and future prospects
Liu, Y., Miao, K., & Yang, X. (2026) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2026.01.001 · Cited by 4
Crosstalk Between Intratumoral Microbes and Tumor Immunity: Implications for Tumor Therapy
Li, F., Qiao, L., Liang, X., Zhang, Y., Liang, N., Xie, J., Deng, G., Hao, Y., Hu, P., Wu, X., et al. (2026) · Cancer Medicine · doi:10.1002/cam4.71575 · Cited by 6
Intratumoral microbiota in cancer: molecular mechanism and therapeutic strategies
Yu, Y., Guo, Z., Luo, Z., Dian, Y., Yang, X., Chen, X., Zeng, F., & Deng, G. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00473-w · Cited by 5
Gut microbiota and metabolic control of immune checkpoint blockade in cancer
Gladstone, J. L., & Sonnenberg, G. F. (2026) · Cell Metabolism · doi:10.1016/j.cmet.2026.04.018 · Cited by 4
Lin, Z., Mu, S., Zhang, W., Guo, Y., Dong, C., Song, L., Zhang, H., Wu, R., Luo, P., & Liang, L. (2026) · Genes & Diseases · doi:10.1016/j.gendis.2026.102428 · Cited by 4
Kashyap, S., & Das, A. (2023) · Acta Microbiologica et Immunologica Hungarica · doi:10.1556/030.2023.02054 · Cited by 5
The Human Blood Harbors a Phageome Which Differs in Crohn's DiseasePreprint
Lamy-Besnier, Q., Theodorou, I., Billaud, M., Zhang, H., Brot, L., Culot, A., Abriat, G., Sokol, H., Paepe, M. D., Petit, M., et al. (2024) · SSRN Electronic Journal · doi:10.1101/2024.06.04.597176 · Cited by 4
Dravillas, C. E., Williams, N. F., Husain, M., Hoyd, R., Hussein, A., Meara, A. S., Lynn, M., Bibi, A., Conrad, B., Lepola, N., et al. (2025) · medRxiv · doi:10.1101/2025.01.30.25321413 · Cited by 5
Al-Matouq, J. A., Hawra, A., Alibrahim, N., Alsaffar, N., Radwan, Z. H., & Ali, M. D. (2025) · Cancers · doi:10.3390/cancers17020226 · Cited by 3
Unveiling cross-reactivity: implications for immune response modulation in cancer
Pretti, M. A. M., Vieira, G. F., Boroni, M., & Bonamino, M. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbaf012 · Cited by 3
Metadata
- Authors
- Fluckiger, A., Daillère, R., Sassi, M., Sixt, B. S., Liu, P., Loos, F., Richard, C., Rabu, C., Alou, M. T., Goubet, A.-G., Lemaitre, F., Ferrere, G., Derosa, L., Duong, C. P. M., Messaoudene, M., Gagné, A., Joubert, P., De Sordi, L., Debarbieux, L., Simon, S., Scarlata, C.-M., Ayyoub, M., Palermo, B., Facciolo, F., Boidot, R., Wheeler, R., Boneca, I. G., Sztupinszki, Z., Papp, K., Csabai, I., Pasolli, E., Segata, N., Lopez-Otin, C., Szallasi, Z., Andre, F., Iebba, V., Quiniou, V., Klatzmann, D., Boukhalil, J., Khelaifia, S., Raoult, D., Albiges, L., Escudier, B., Eggermont, A., Mami-Chouaib, F., Nistico, P., Ghiringhelli, F., Routy, B., Labarrière, N., Cattoir, V., Kroemer, G., & Zitvogel, L.
- Affiliations
- Inserm (FR)
- Université de Bourgogne (FR)
- Gustave Roussy Cancer Campus (GRCC), Villejuif, France.
- Institut universitaire de cardiologie et de pneumologie de Québec (CA)
- Bacteriophage, Bacterium, Host Laboratory, Institut Pasteur, F-75015 Paris, France.
- Institut Pasteur (FR)
- Université Toulouse III - Paul Sabatier (FR)
- Instituto Nazionale Tumori Regina Elena (IT)
- Centre Georges François Leclerc (FR)
- Computational Health Informatics Program (CHIP), Boston Children's Hospital, Boston, MA, USA.
- Department of Physics of Complex Systems, ELTE Eötvös Loránd University, Budapest, Hungary.
- University of Naples Federico II (IT)
- University of Trento (IT)
- Equipe 11 labellisée Ligue contre le Cancer, Centre de Recherche des Cordeliers, Paris, France.
- Department of Cancer Medicine, Breast Cancer Committee, Gustave Roussy, Villejuif, France.
- University of Trieste (IT)
- UMR MEPHI, Aix-Marseille Université, IRD, AP-HM, Institut Hospitalo-Universitaire Méditerranée-Infection, 19-21 Boulevard Jean Moulin, 13385, Marseille cedex 05, France.
- Aix-Marseille Université (FR)
- Institut Gustave Roussy (FR)
- INSERM UMR 1186, Integrative Tumor Immunology and Immunotherapy, Gustave Roussy, Fac. de Médecine - Univ. Paris-Sud, Université Paris-Saclay, 94805, Villejuif, France.
- Unit of Tumor Immunology and Immunotherapy, Department of Research, Advanced Diagnostics and Technological Innovation, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
- Karolinska University Hospital (SE)
- Corresponding author
- Kroemer, Guido
- Zitvogel, Laurence
- ORCID
- Fluckiger, Aurélie
- Daillère, Romain
- Sassi, Mohamed
- Sixt, Barbara Susanne
- Liu, Peng
- Loos, Friedemann
- Richard, Corentin
- Rabu, Catherine
- Alou, Maryam Tidjani
- Goubet, Anne-Gaëlle
- Lemaitre, Fabien
- Ferrere, Gladys
- Derosa, Lisa
- Duong, Connie P. M.
- Messaoudene, Meriem
- Gagné, Andréanne
- Joubert, Philippe
- De Sordi, Luisa
- Debarbieux, Laurent
- Simon, Sylvain
- Scarlata, Clara-Maria
- Ayyoub, Maha
- Palermo, Belinda
- Facciolo, Francesco
- Boidot, Romain
- Wheeler, Richard
- Boneca, Ivo Gomperts
- Sztupinszki, Zsofia
- Papp, Krisztian
- Csabai, Istvan
- Pasolli, Edoardo
- Segata, Nicola
- Lopez-Otin, Carlos
- Szallasi, Zoltan
- Andre, Fabrice
- Iebba, Valerio
- Quiniou, Valentin
- Klatzmann, David
- Khelaifia, Saber
- Raoult, Didier
- Albiges, Laurence
- Escudier, Bernard
- Eggermont, Alexander
- Nistico, Paola
- Ghiringhelli, François
- Routy, Bertrand
- Labarrière, Nathalie
- Cattoir, Vincent
- Kroemer, Guido
- Zitvogel, Laurence
- Venue
- Science
- Published
- 2020-08-21
- Volume
- 369
- Issue
- 6506
- Pages
- 936-942
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W3081393016
- Cited by
- 396
- References
- 53
- Citations by year
- 2026: 47 · 2025: 77 · 2024: 59 · 2023: 80 · 2022: 61 · 2021: 62 · 2020: 9
- FWCI
- 18.57
- Type
- journal article
- Language
- en
- Open access
- green
- inserm.hal.science
- Licence
- other-oa
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/) (submittedVersion, other-oa)
- Institutional Research Information System (Università degli Studi di Trento) (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-10-LABX-0015, ANR-19-CE15-0029, ANR-16-RHUS-0008)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Virology › Bacteriophages and microbial interactions
- Keywords
- bacteriophages, Enterococcus, cross-reactivity, molecular mimicry, tumor antigens, T cell response, gut microbiota, cancer immunotherapy, anti-PD-1 therapy, chemotherapy, microbial peptides, immune checkpoint inhibitors
- MeSH terms
- Gastrointestinal Microbiome, Enterococcus hirae, Animals, Antibodies, Monoclonal, Epitopes, Antigens, Neoplasm, Bacteriophages, Cross Reactions, Cyclophosphamide, Feces, H-2 Antigens, Humans, Immunotherapy, Neoplasms, Histocompatibility Antigens Class I, Viral Tail Proteins, CD8-Positive T-Lymphocytes, Antineoplastic Agents, Alkylating, Mice, Programmed Cell Death 1 Receptor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.